Real-world comparative effectiveness of sotorasib versus docetaxel monotherapy in second line and beyond for advanced or metastatic non-small cell lung cancer: A national database analysis from England
{{output}}
Purpose: To compare sotorasib versus docetaxel monotherapy real-world outcomes in second line and beyond (2 L+) for locally advanced or metastatic non-small cell lung cancer (NSCLC). ... ...
